Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions.
Yellow Card scheme
adverse drug reactions
public awareness
Journal
British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
27
11
2020
received:
07
10
2020
accepted:
21
12
2020
pubmed:
3
1
2021
medline:
28
10
2021
entrez:
2
1
2021
Statut:
ppublish
Résumé
We used the HealthWise Wales (HWW) platform to explore public knowledge about the UK Yellow Card scheme (YCS), the spontaneous reporting scheme for suspected adverse drug reactions (ADRs) and whether a short information video could improve awareness. Members of the public in Wales (n = 1606) completed a questionnaire about the YCS, watched the information video and then completed a follow-up questionnaire. Almost half (46.5%) of respondents said they had previously experienced an ADR (>90% of the ADRs involving prescribed medicines). Before the video, 18% of respondents knew how to report an ADR via the YCS and of these, 34% were from allied-health professions. Immediately after watching it, 71% participants reported knowing how to report and 82% reported being confident to report. If this awareness were maintained, such an approach could contribute to improved reporting of suspected ADRs by the public.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3344-3348Informations de copyright
© 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.
Références
Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316(7140):1295-1298.
McNaughton R, Huet G, Shakir S. An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision making. BMJ Open. 2014;4(1):e004221. https://doi.org/10.1136/bmjopen-2013-004221
McLernon DJ, Bond CM, Lee AJ, et al. Patient views and experiences of making adverse drug reaction reports to the Yellow Card Scheme in the UK. Pharmacoepidemiol Drug Saf. 2011;20(5):523-53114.
Aldeyab AA, Noble SC, Cuthbert M, Maxwell S, Dear J, Boyter A. Assessment of the impact of the Scottish public health campaign on patient reporting of adverse drug reactions. Drugs Therap Persp. 2016;32(5):209-218.
Avery AJ, Anderson C, Bond CM, et al. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess. 2011;15(20):1-234.
Hurt L, Ashfield-Watt P, Townson J, et al. Cohort profile: HealthWise Wales. A research register and population health data platform with linkage to National Health Service data sets in Wales. BMJ Open. 2019;9:e031705. https://doi.org/10.1136/bmjopen-2019-031705
Welsh Government. Welsh Index of Multiple Deprivation 2011. https://gov.wales/sites/default/files/statistics-and-research/2019-04/welsh-index-of-multiple-deprivation-2011-summary-report_0.pdf. Accessed September 28, 2020.
Jones KH, Ford DV, Jones C, et al. A case study o f the Secure Anonymous Information Linkage (SAIL) Gateway: A privacy-protecting remote access system for health-related research and evaluation. J Biomed Inform. 2014;50:196-204.
Fortnum H, Lee AJ, Rupnik B, Avery A. Yellow Card Study Collaboration. Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. J Clin Pharm Ther. 2012;37(2):161-165.
Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol. 2007;63(2):148-156.
Valery J, Helmi H, Spaulding A, et al. Video intervention to improve incident reporting among medical trainees. BMJ Open Qual. 2019;8(4):e000706. https://doi.org/10.1136/bmjoq-2019-000706
Anderson C, Krska J, Murphy E, Avery A. Yellow Card Study Collaboration. The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol. 2011;72(5):806-822.
Ipsos MORI. The Risks and Benefits of Medicines and Medical Devices - Perceptions, Communication & Regulation 2006. https://www.ipsos.com/sites/default/files/migrations/en-uk/files/Assets/Docs/Archive/Polls/mhra-gp-qual.pdf. Accessed September 28, 2020.
McKinstry B, Sullivan FM, Vasishta S, et al. Cohort profile: the Scottish research register share. A register of people interested in research participation linked to NHS data sets. BMJ Open. 2017;7:e013351. https://doi.org/10.1136/bmjopen-2016-013351
Fry A, Littlejohns TJ, Sudlow C, et al. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population. Am J Epidemiol. 2017;186(9):1026-1034.